[go: up one dir, main page]

NO941191D0 - Partikler, fremgangsmåte for fremstilling samt anvendelse av slike - Google Patents

Partikler, fremgangsmåte for fremstilling samt anvendelse av slike

Info

Publication number
NO941191D0
NO941191D0 NO941191A NO941191A NO941191D0 NO 941191 D0 NO941191 D0 NO 941191D0 NO 941191 A NO941191 A NO 941191A NO 941191 A NO941191 A NO 941191A NO 941191 D0 NO941191 D0 NO 941191D0
Authority
NO
Norway
Prior art keywords
particles
manufacture
Prior art date
Application number
NO941191A
Other languages
English (en)
Other versions
NO941191L (no
Inventor
Tomas Landh
Kaare Larsson
Original Assignee
Gs Biochem Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Biochem Ab filed Critical Gs Biochem Ab
Publication of NO941191D0 publication Critical patent/NO941191D0/no
Publication of NO941191L publication Critical patent/NO941191L/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO941191A 1991-10-04 1994-03-30 Partikler, fremgangsmåte for fremstilling samt anvendelse av slike NO941191L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77101491A 1991-10-04 1991-10-04
PCT/SE1992/000692 WO1993006921A1 (en) 1991-10-04 1992-10-02 Particles, method of preparing said particles and uses thereof

Publications (2)

Publication Number Publication Date
NO941191D0 true NO941191D0 (no) 1994-03-30
NO941191L NO941191L (no) 1994-06-01

Family

ID=26661355

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941191A NO941191L (no) 1991-10-04 1994-03-30 Partikler, fremgangsmåte for fremstilling samt anvendelse av slike

Country Status (2)

Country Link
NO (1) NO941191L (no)
WO (1) WO1993006921A1 (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
CA2108266C (en) * 1991-04-19 2003-06-03 Albert J. Owen Convertible microemulsion formulations
EP0736041B1 (en) * 1993-11-17 2006-02-08 Athena Neurosciences, Inc. Transparent liquid for encapsulated drug delivery
FR2720937B1 (fr) * 1994-06-08 1997-03-28 Oreal Composition cosmétique ou dermatologique sous forme de dispersion, aqueuse et stable, de particules de gel cubique à base de phytantriol et contenant un agent tensioactif à chaîne grasse en tant qu'agent dispersant et stabilisant.
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
SE9602280D0 (sv) * 1996-06-10 1996-06-10 Pharmatrix Ab Immunstimulerande lipidformulering
ZA975263B (en) * 1996-06-13 1998-07-27 Thomas L Mehl Sr Liquid crystals in dermatological treatments using light energy
US6306433B1 (en) 1997-08-12 2001-10-23 Pharmacia Ab Method of preparing pharmaceutical compositions
US6638621B2 (en) 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
ATE246039T1 (de) * 1997-09-09 2003-08-15 Select Release L C Beschichtete teilchen, methode zu ihrer herstellung und verwendung
EP0948902A1 (fr) 1998-03-13 1999-10-13 Societe Des Produits Nestle S.A. Composition alimentaire contenant une phase mésomorphe de monoglycéride
SE9900495D0 (sv) * 1999-02-12 1999-02-12 Pharmatrix Ab Vaccine composition
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6458383B2 (en) 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US20020153508A1 (en) 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
DE10057770A1 (de) * 2000-11-22 2002-05-23 Beiersdorf Ag Hautpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen ,
SE527505C2 (sv) * 2003-06-10 2006-03-28 Anna Imberg Komposita material och partiklar
US7713440B2 (en) * 2003-10-08 2010-05-11 Lyotropic Therapeutics, Inc. Stabilized uncoated particles of reversed liquid crystalline phase materials
FR2861988B1 (fr) * 2003-11-07 2006-01-06 Oreal Utilisation cosmetique de particules de gel cubique en tant qu'agent empechant ou reduisant l'adhesion des microorganismes sur la surface de la peau et/ou des muqueuses
EP1778187B1 (en) * 2004-08-04 2012-05-23 Camurus Ab Compositions forming non-lamellar dispersions
CA2594711C (en) * 2005-01-14 2012-11-06 Camurus Ab Somatostatin analogue formulations
US8871712B2 (en) 2005-01-14 2014-10-28 Camurus Ab Somatostatin analogue formulations
US9649382B2 (en) 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
EP2206495B1 (en) 2005-01-14 2012-11-21 Camurus AB Topical bioadhesive formulations
GB0501364D0 (en) * 2005-01-21 2005-03-02 Camurus Ab Compositions
CA2595385C (en) * 2005-01-21 2011-01-25 Camurus Ab Pharmaceutical lipid compositions
US7125954B2 (en) 2005-01-27 2006-10-24 General Electric Company Method for producing polyether polymers
CA2609810C (en) 2005-06-06 2012-05-22 Camurus Ab Glp-1 analogue formulations
EP1954384A1 (en) * 2005-11-23 2008-08-13 Nestec S.A. Oil-in-water emulsion for creating new product consistencies
US8021570B2 (en) 2006-06-13 2011-09-20 Wisconsin Alumni Research Foundation β-peptide lyotropic liquid crystals and methods of manufacture and use thereof
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
AU2013265210B2 (en) 2012-05-25 2016-09-15 Camurus Ab Somatostatin receptor agonist formulations
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016205423A2 (en) 2015-06-15 2016-12-22 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
CA3078723A1 (en) 2016-11-28 2018-05-31 Nachiappan Chidambaram Oral testosterone undecanoate therapy
SE541313C2 (en) * 2017-10-13 2019-06-25 Amferia Ab Amphiphilic antimicrobial hydrogel
US12150945B2 (en) 2018-07-20 2024-11-26 Lipocine Inc. Liver disease
EP4141110A4 (en) 2020-04-24 2025-04-09 Sf Biotech Laboratuvar Danismanlik Anonim Sirketi Method for producing particles of bacteriophages of the genus levivirus
WO2023225722A1 (en) * 2022-05-26 2023-11-30 Royal Melbourne Institute Of Technology Lipid nanocarrier vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
US4556289A (en) * 1983-03-21 1985-12-03 Manchester R & D Partnership Low birefringence encapsulated liquid crystal and optical shutter using same
GB8803037D0 (en) * 1988-02-10 1988-03-09 Unilever Plc Aqueous detergent compositions & methods of forming them
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals

Also Published As

Publication number Publication date
WO1993006921A1 (en) 1993-04-15
NO941191L (no) 1994-06-01

Similar Documents

Publication Publication Date Title
NO941191D0 (no) Partikler, fremgangsmåte for fremstilling samt anvendelse av slike
NO940996D0 (no) Fremgangsmåte for fremstilling, samt anvendelse av oksygenanriket gass
KR950701061A (ko) 방탄제품 및 이의 제조방법(Ballistic-resistane articlt and process for making the same)
ZA919040B (en) Process and device for the manufacture of filamentary abrasive particles
NO843515L (no) Fremgangsmaate for fremstilling av lipase, samt anvendelse av produktet
DE69201589D1 (de) Wachsumhüllte Partikel und Verfahren zur Herstellung derselben.
NO974557D0 (no) Fremgangsmåte for fremstilling av respirerbare partikler
FI934686L (fi) En process foer beklaednad av oorganiska partiklar
NO900439D0 (no) Fremgangsmaate for behandling av uorganisk pulver.
DK0562583T3 (da) Hidtil ukendte alkylendiammoniumdiclavulanatderivater, fremgangsmåde til fremstilling deraf samt anvendelse deraf
NO934057L (no) Fremgangsmåte for fremstilling av rent nikkelhydroksyd samt anvendelse av dette
FI951724A0 (fi) Menetelmä päälystettyjen hiukkasten valmistamiseksi
NO960089D0 (no) Fremgangsmåte for fremstilling av homo- og kopolymerisater av alk-1-ener
EP0475046A3 (en) Method for production of granules containing zincoxide and silica, the granules and their use
DE69325234D1 (de) Toner und dessen Herstellungsverfahren
NO890235L (no) Fremgangsmaate til agglomerering av partikler.
NO931400D0 (no) Derivater av adipogeneseinhiberende faktor, samt fremstilling og anvendelse derav
NO933399D0 (no) Anordning og fremstilling av syntesegass, samt anvendelseav anordningen
NO903004D0 (no) Fremgangsmaate for hvittoning av papirbestrykningsmasser samt hvittoningspreparater for fremgangsmaaten.
GR3022448T3 (en) Process for the manufacture of 2-alkoxymethylacrolein and its use for preparing 3-alkoxymethyl quinolines
NO904016L (no) Paafoerings-hjelpemiddel samt anvendelse av dette.
NO179101C (no) Fremgangsmåte for fremstilling av dibeskyttet 2,3-hydroksymetyl-cyklobutanol
NO302416B1 (no) Fremgangsmåte for fremstilling av pergolid
NO942531D0 (no) Fremgangsmåte for fremstilling av 3-acylöstratriener og acylbenzener
NO302421B1 (no) Fremgangsmåte for rensing av faste partikler